The efficacy of the BCG vaccine varies widely by geography and population. It provides robust protection against severe forms of TB, such as TB meningitis and miliary TB, especially in children. However, its effectiveness in preventing pulmonary TB in adults is more variable, ranging from 0% to 80%. The variation in efficacy is thought to be due to differences in environmental mycobacteria, genetic factors, and previous exposure to TB.
